Home / Aripiprazole / Czechia
CZ ATC N05AX12 · updated 2 Nov 2026
Aripiprazole shortage in Czechia
Is there an Aripiprazole shortage in Czechia?
Yes. As of 2 Nov 2026, 25 Aripiprazole products are reported short in Czechia, the first since 15 Feb 2024. The company estimate for the return is 20 Nov 2026 (latest 1 Jun 2028). Main reason: commercial decision or withdrawal.
Also short in Italy, Spain, Ireland, Austria, Belgium, Sweden, Japan, Australia. All countries.
Affected products in Czechia
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CZ | ARIPIPRAZOLE TEVA 10MG 10MG TBL NOB 56 | Teva Pharmaceuticals CR, s.r.o., Praha | 15 Feb 2024 | 31 May 2027 | Commercial decision or withdrawal Obchodní/marketingové důvody |
| CZ | ARIPIPRAZOLE TEVA 10MG 10MG TBL NOB 28 | Teva Pharmaceuticals CR, s.r.o., Praha | 31 Mar 2024 | 31 May 2027 | Commercial decision or withdrawal Obchodní/marketingové důvody |
| CZ | ARIPIPRAZOLE TEVA 15MG 15MG TBL NOB 28 | Teva Pharmaceuticals CR, s.r.o., Praha | 4 Apr 2024 | 31 May 2027 | Commercial decision or withdrawal Obchodní/marketingové důvody |
| CZ | ARIPIPRAZOLE TEVA 15MG 15MG TBL NOB 56 | Teva Pharmaceuticals CR, s.r.o., Praha | 11 Apr 2024 | 31 May 2027 | Commercial decision or withdrawal Obchodní/marketingové důvody |
| CZ | ZYKALOR 10MG 10MG TBL NOB 84 | Medochemie Ltd., Limassol | 15 Aug 2025 | 1 Sep 2027 | Commercial decision or withdrawal Obchodní/marketingové důvody |
| CZ | ZYKALOR 15MG 15MG TBL NOB 84 | Medochemie Ltd., Limassol | 15 Aug 2025 | 1 Sep 2027 | Commercial decision or withdrawal Obchodní/marketingové důvody |
| CZ | ZYKALOR 10MG 10MG TBL NOB 30 | Medochemie Ltd., Limassol | 31 Dec 2025 | 3 Jan 2028 | Commercial decision or withdrawal Obchodní/marketingové důvody |
| CZ | ZYKALOR 15MG 15MG TBL NOB 30 | Medochemie Ltd., Limassol | 31 Dec 2025 | 3 Jan 2028 | Commercial decision or withdrawal Obchodní/marketingové důvody |
| CZ | ZYKALOR 15MG 15MG TBL NOB 90 | Medochemie Ltd., Limassol | 1 May 2026 | 1 Jun 2028 | Commercial decision or withdrawal Obchodní/marketingové důvody |
| CZ | ZYKALOR 10MG 10MG TBL NOB 90 | Medochemie Ltd., Limassol | 25 May 2026 | 1 Jun 2028 | Commercial decision or withdrawal Obchodní/marketingové důvody |
| CZ | ARIPIPRAZOLE SANDOZ 15MG 15MG TBL NOB 28 | Sandoz GmbH, Kundl | 8 Jun 2026 | 20 Nov 2026 | Manufacturing problem Výrobní důvody |
| CZ | ARIPIPRAZOLE TEVA 15MG 15MG TBL NOB 30 | Teva Pharmaceuticals CR, s.r.o., Praha | 19 Jul 2026 | 29 Feb 2028 | Commercial decision or withdrawal Obchodní/marketingové důvody |
| CZ | ARIPIPRAZOL +PHARMA 15MG 15MG TBL NOB 28 | +pharma arzneimittel gmbh, Graz | 31 Jul 2026 | 1 Apr 2027 | Commercial decision or withdrawal Obchodní/marketingové důvody |
| CZ | ARIPIPRAZOLE TEVA 10MG 10MG TBL NOB 60 | Teva Pharmaceuticals CR, s.r.o., Praha | 11 Aug 2026 | 30 Nov 2027 | Commercial decision or withdrawal Obchodní/marketingové důvody |
| CZ | ARIPIPRAZOLE SANDOZ 10MG 10MG TBL NOB 30 | Sandoz GmbH, Kundl | 17 Aug 2026 | 1 Nov 2027 | Commercial decision or withdrawal Obchodní/marketingové důvody |
| CZ | ARIPIPRAZOLE SANDOZ 15MG 15MG TBL NOB 30 | Sandoz GmbH, Kundl | 17 Aug 2026 | 1 Nov 2027 | Commercial decision or withdrawal Obchodní/marketingové důvody |
| CZ | ARIPIPRAZOLE TEVA 10MG 10MG TBL NOB 30 | Teva Pharmaceuticals CR, s.r.o., Praha | 3 Sep 2026 | 30 Nov 2027 | Commercial decision or withdrawal Obchodní/marketingové důvody |
| CZ | ARIPIPRAZOLE SANDOZ 10MG 10MG TBL NOB 56 | Sandoz GmbH, Kundl | 2 Oct 2026 | 2 Apr 2027 | Commercial decision or withdrawal Obchodní/marketingové důvody |
| CZ | ARIPIPRAZOLE TEVA 15MG 15MG TBL NOB 49 | Teva Pharmaceuticals CR, s.r.o., Praha | 5 Oct 2026 | 28 Feb 2027 | Manufacturing problem Výrobní důvody |
| CZ | ARIPIPRAZOLE SANDOZ 10MG 10MG TBL NOB 28 | Sandoz GmbH, Kundl | 6 Oct 2026 | 17 Dec 2026 | Manufacturing problem Výrobní důvody |
| CZ | ARIPIPRAZOLE SANDOZ 15MG 15MG TBL NOB 56 | Sandoz GmbH, Kundl | 7 Oct 2026 | 16 Apr 2027 | Manufacturing problem Výrobní důvody |
| CZ | ARIPIPRAZOLE TEVA 15MG 15MG TBL NOB 60 | Teva Pharmaceuticals CR, s.r.o., Praha | 12 Oct 2026 | 29 Feb 2028 | Commercial decision or withdrawal Obchodní/marketingové důvody |
| CZ | ZYKALOR 10MG 10MG TBL NOB 60 anticipated | Medochemie Ltd., Limassol | 1 Dec 2026 | 1 Jun 2028 | Commercial decision or withdrawal Obchodní/marketingové důvody |
| CZ | ZYKALOR 15MG 15MG TBL NOB 60 anticipated | Medochemie Ltd., Limassol | 1 Dec 2026 | 1 Jun 2028 | Commercial decision or withdrawal Obchodní/marketingové důvody |
| CZ | ARIPIPRAZOLE TEVA 10MG 10MG TBL NOB 49 anticipated | Teva Pharmaceuticals CR, s.r.o., Praha | 7 Jan 2027 | 30 Jun 2027 | Manufacturing problem Výrobní důvody |
Source
SÚKL (State Institute for Drug Control), market reports. Official list. Products whose latest market report is a supply interruption; one row per SÚKL code.